Artificial Intelligence (AI) in Medical Diagnostics Market Share, Size, Trends, Industry Analysis Report
By Component (Software, Hardware, and Services); By Application; By End User; By Region; Segment Forecast, 2025 - 2034
- Published Date: Nov-2025
- Pages: 116
- Format: PDF
- Report ID: PM3407
- Base Year: 2024
- Historical Data: 2020-2023
What is the Current Market SIze?
The global artificial intelligence (AI) in medical diagnostics market was valued at USD 1.82 billion in 2024 and is expected to grow at a CAGR of 39.5% during the forecast period. Key factors driving the market includes increasing use of AI in chronic disease management, access to smart electronic medical records, advancements in the healthcare IT infrastructure and technological developments in computer processing, machine learning algorithms, and cloud storage.
Key Insights
- In 2024, the software segment held the largest share of the market due to the rapid increase in the global population, which is being increasingly diagnosed with a large array of chronic and acute diseases.
- The in vivo diagnostics segment dominated the market revenue share in 2024. This is due to the growing demand to detect diseases and many other conditions and to monitor patient’s health to help cure, treat, and prevent diseases.
- In 2024, North America held the largest share of the market. This is due to the rise in healthcare spending with the early adoption of advanced AI diagnostic tools.
- Asia Pacific is expected to witness the fastest growth during the forecast period. This is due to the growing number of private and public initiatives adopting AI-based medical diagnostic solutions, along with increasing recognition and funding.
Industry Dynamics
- Complex healthcare data sources, such as digital records and scans, boost the need for refined artificial intelligence for medical diagnostics.
- The rise in demand for AI to boost services in healthcare and pharmaceuticals, and to improve disease monitoring, further increases demand.
- Unbiased, high-quality data for training of the AI models creates challenges as this type of data lead to unsafe and inaccurate diagnostics.
- Diagnostics speed and accuracy enhancement for conditions such as cancer allows early intervention and improved outcomes of chronic disease.
Market Statistics
- 2024 Market Size: USD 1.82 billion
- 2034 Projected Market Size: USD 50.31 billion
- CAGR (2025-2034): 39.5%
- North America: Largest market in 2024
What Does the Current Market Landscape Look for Artificial Intelligence (AI) in Medical Diagnostics?
Artificial intelligence in medical diagnosis assists with medical administration, management, automation, admin, and enterprise. It can be utilized to detect cancer, triage crucial detections in medical imaging, point out critical deformities, offer radiologists assistance in organizing life-threatening situations, detect cardiac arrhythmias, forecast stroke results, and assist with the handling of detrimental illnesses. AI is a prosperous dominion of algorithms, data, analytics, deep learning, neural meshwork, and perceptions that are continuously evolving and adjusting to the requirements of the healthcare industry and its patients.
Artificial intelligence carries pronounced promise in assisting healthcare donors to acquire perception and enhance healthcare results. Although several questions remain regarding its security, control, and influence, the usage of AI in clinical care is not limited to infancy and is anticipated to encounter substantial development in the near future. The artificial intelligence (AI) in medical diagnostics market size is expanding as AI is enhancing data processing, recognizing motifs, and creating perceptions that might, in other respects, evade detection from a physician's physical endeavor.
Rapid increase in the integration of artificial intelligence powered solutions across wide range of verticals for achieving better operational & clinical outcomes and rising prevalence of chronic diseases, that is creating huge demand for highly automated and innovative healthcare processes are key factors driving the growth of the market. In order to meet the growing need of AI in medical diagnostics to reduce human errors shortage of healthcare professionals, and provide better treatment facilities, major players are focusing on developing and introducing new solutions with advanced features, that is further influencing the market at rapid pace.
 in Medical Diagnostics Market.png)
To Understand More About this Research: Request a Free Sample Report
For instance, in December 2022, Digistain, announced the launch of its new revolutionary AI-based breast cancer diagnostic tool, that has passed clinical studies and gained clearance from the Medicines & Healthcare Regulatory Agency. This technology is quicker, cheaper, and effectively identifies patients who could safely avoid chemotherapy with over 99% accuracy.
Moreover, continuous advancements in the healthcare IT infrastructure and technological developments in computer processing, machine learning algorithms, and cloud storage, are significantly supporting the integration of AI-based systems in diagnostics for providing accurate & efficient diagnosis. In the recent years, big data and analytics solutions are being largely adopted especially with the rising use of EHRs, high-resolution radiology images, and digitized laboratory slides, that is opening huge potential for the market in the near future.
However, the high cost associated with the implementation & licensing of AI software and expensive imaging equipment especially in the low-income countries with lack of technology and access to advanced healthcare facilities, are major factors hindering the market growth.
 in Medical Diagnostics Market New.png)
Industry Dynamics
What Factors are Driving the Market?
Growth Drivers
Several large and complex data is generated at numerous stages in care delivery process and big data and analytical solutions have drastically grown in sophistication with the surging adoption of EHRs, digitized laboratory slides, and high-resolution radiology images with the extensive growth in the digitization trend and adoption of information systems across the healthcare industry, which are the primary factors fueling the demand and growth of the artificial intelligence (AI) in medical diagnostics market.
Furthermore, increasing practice of artificial intelligence in the areas of drug discovery, genomics, medical imaging sector, and precision medicine coupled with the various cumulative custom-made treatments tailored to particular patient necessity are also expected to boost the market growth. Escalating need and demand for artificial intelligence technology to accomplish data mining and fuel the healthcare delivery services speed and introduction to innovative and encouraging uses for the disease monitoring and identification across the globe, is further accelerating the demand and growth of the global market at significant pace.
Report Segmentation
The market is primarily segmented based on component, application, end user, and region.
|
By Component |
By Application |
By End User |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
What are the Segmental Insights?
Software Analysis
Software segment held the largest share of the market in 2024. The growth is largely attributed to its ability to provide healthcare providers a competitive edge over others, without facing several types of challenges including being short-staffed and surging imaging scan volumes. The rapid increase in the global population, that is being increasingly diagnosed with large array of chronic and acute diseases, has paved the pay for higher adoption of advanced AI-enabled solutions. The surge in the burden of healthcare infrastructure and lack of care providers along with the constant advancements in the healthcare systems and electronic health records with the implementation of AI-based solutions, are further likely to boost the growth of the segment in the coming years.
Application Analysis
The in vivo diagnostics segment dominated the market revenue share in 2024. The continuous increase in the adoption and prevalence for these AI solutions across healthcare and medical industry due to its numerous advantages such as reducing the human errors and improve overall treatment efficacy. Moreover, the in vitro diagnostics segment is expected to exhibit significant market growth over the coming years, on account of growing demand for these solutions to detect diseases and many other conditions and are being widely used to monitor patient’s health to help cure, treat, and prevent diseases. In addition, it is also used in the precision medicine to identify patients, who are likely to have benefitted from several specific treatments and therapies, which is fostering the growth of the market.
-in-medical-diagnostics-market-by-type-analysis-2020-2034.webp)
Why North America Dominated the Global Market?
The North America region led the global market, accounting for the largest share of the market in 2024 due to the presence of the presence of established healthcare IT infrastructure, continual market advancements in technology including several advanced healthcare-based startups, the high levels of digital literacy, and a large number of conducive government initiatives, are among some prominent reasons contributing to the demand and growth of the market in this region. This is further driven by the rise in healthcare spending with the early adoption of advanced AI diagnostic tools. Moreover, partnerships between firms in technology, academic research centers, and hospital networks supports innovation and clinical integration to advance products into clinical practice.Therefore, the high prevalence of chronic disease in the region supports the continued demand for efficient diagnostic solutions in healthcare.
What are the Factors Contributing to the Growth of Asia Pacific?
Asia Pacific region is anticipated to be the fastest growing region with a healthy CAGR in the coming years, owing to growing number of private and public initiatives towards the adoption of AI-based medical diagnostic solutions and rising recognition and funding in countries like China, India, and Malaysia. Additionally, the high prevalence for adoption several growth strategies by key players in the emerging economies and constant digitization of diagnostic infrastructure along with the growing geriatric population and rapid increase in cancer patients in the region, will further stimulate the growth of the market. According to Indian Council of Medical Research, the total number of cancer cases in India was estimated around 1.46 million in 2022, and is likely to reach over 1.57 million by 2025. One in every nine Indian is expected to have cancer in their lifetime, as the disease might increase by 12.8% from 2020 to 2025.
-in-medical-diagnostics-market-trends-by-region-2020-2034.webp)
Competitive Insight
Some of the major players operating in the global market include Intel Corporation, Google, IBM Corporation, Microsoft Corporation, Enlitic Inc., Siemens Healthcare, Zebra Medical Vision Inc., Riverain Technologies, Imagen Technologies, GE Healthcare, Digital Diagnostics, HeartFlow, Arterys, VUNO Inc., NovaSignal Corporation, and Agfa-Gevaert.
Recent Developments
- In April 2024, Happiest Mind Technologies Limited announced its partnership with MindSculpt Analytics. The new collaboration aims at leveraging artificial intelligence and machine learning technologies to offer advanced medical diagnostic solutions that focus on individual health and wellness.
- In December 2023, leading data analytics firm Enlitic announced it is entering into contractual agreements with global enterprise imaging partner Endex. The new collaboration aims at improving the standardization of medical imaging data. With the new partnership, Enlitic's data standardization software Endex will be integrated with Infinitt PACS.
- In November 2021, Royal Philips, introduced AI based MR portfolio of the diagnostic systems that has received the 510(k) clearance from the FDA. It helps is simplifying and automating complex clinical and operational tasks with the helium-free for life MR operations. The system is specially used to speed MR exams, smooth workflows, help ensuring the efficiency, and optimize diagnostic quality.
- In June 2021, Max Healthcare, introduced its new artificial intelligence powered device in collaboration with MyHealthcare, a digital health solutions provider, that is integrated with patient monitoring framework. Patients can easily use the platform Max MyHealth to monitor their vitals with clinical devices associated with the app.
Artificial Intelligence (AI) in Medical Diagnostics Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 1.82 billion |
| Market size value in 2025 | USD 2.52 billion |
|
Revenue forecast in 2034 |
USD 50.31 billion |
|
CAGR |
39.5% from 2025– 2034 |
|
Base year |
2024 |
|
Historical data |
2020– 2023 |
|
Forecast period |
2025– 2034 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2025 to 2034 |
|
Segments covered |
By Component, By Application, By End User, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key companies |
Intel Corporation, Google Inc., IBM Corporation, Microsoft Corporation, Enlitic Inc., Siemens Healthcare, Zebra Medical Vision Inc., Riverain Technologies, Imagen Technologies, GE Healthcare, Digital Diagnostics Inc., HeartFlow Inc., Arterys Inc., VUNO Inc., NovaSignal Corporation, and Agfa-Gevaert Group. |
FAQ's
The global artificial intelligence (AI) in medical diagnostics market size is expected to reach USD 50.31 Billion by 2034.
Key players in the artificial intelligence (AI) in medical diagnostics market are Intel Corporation, Google, IBM Corporation, Microsoft Corporation, Enlitic Inc., Siemens Healthcare, Zebra Medical Vision Inc.
North America dominated the market in 2024.
The global artificial intelligence (AI) in medical diagnostics market is expected to grow at a CAGR of 39.5% during the forecast period.
The artificial intelligence (AI) in medical diagnostics market report covering key segments are component, application, end user, and region.
© 2026 Polaris Market Research and Consulting. All rights reserved
